Aethlon Medical (NASDAQ:AEMD) Now Covered by StockNews.com

StockNews.com initiated coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a research report report published on Saturday. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 target price on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Stock Performance

Shares of AEMD stock opened at $0.64 on Friday. The company has a market capitalization of $8.87 million, a price-to-earnings ratio of -0.23 and a beta of 1.61. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.10. The company has a 50-day simple moving average of $0.50 and a two-hundred day simple moving average of $0.43.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.